Northern, WI 05/17/2013 (usmarketsdaily) - The prices of Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) currently trading at $60.74, down by 1.56%. The stock opened at $61.73. The company witnessed trading in high volumes at 500.00 shares. This is overtly below compared to the average volume of trading of Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) at 686,715.00 shares.
Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) is a biopharmaceutical company which focuses on the development and commercialization of therapeutics to treat lipid disorders. The stock is almost reaching its 52 week high of $63.72 for the year. The previous trading session witnessed the shares of Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) trading in the range of $47.45 to $63.72 for the entire day.
The analysts now have a buy rating on the stock and the price targets fixed for the shares of Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) had been rising from the beginning of this month. The market capitalization of the biopharmaceutical company is $1.78 billion and the institutional holding of shares in Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) is around 96 percent.
While the price target was fixed at $50 by analysts at Needham & company in the beginning of this month, the share price of Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) had now reached a price target revised from $53 to $65 by analysts at Lazard capital markets. The shares of Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) are fast moving towards positive buy ratings with their present 50 day moving average at $38.45.
